Valproate-Induced Reversible HemichoreaSRINIVASAN, Sheila; AU WING LOK.Movement disorders. 2010, Vol 25, Num 10, pp 1511-1512, issn 0885-3185, 2 p.Article

Late Adverse Effects of the Coadministration of Valproate and LamotrigineTHOME-SOUZA, Sigride; MOREIRA, Bernardo; VALENTE, Kette D et al.Pediatric neurology. 2012, Vol 47, Num 1, pp 47-50, issn 0887-8994, 4 p.Article

Meropenem decreases serum level of valproic acidNACARKUCUK, Ergun; SAGLAM, Halil; OKAN, Mehmet et al.Pediatric neurology. 2004, Vol 31, Num 3, pp 232-234, issn 0887-8994, 3 p.Article

Metabolic Alterations During Valproic Acid Treatment: A Prospective StudyABACI, Ayhan; SAYGI, Murat; YIS, Uluc et al.Pediatric neurology. 2009, Vol 41, Num 6, pp 435-439, issn 0887-8994, 5 p.Article

Valproic acid adjunctive therapy for HIV-associated cognitive impairment : A first reportSCHIFITTO, G; PETERSON, D. R; ZHONG, J et al.Neurology. 2006, Vol 66, Num 6, pp 919-921, issn 0028-3878, 3 p.Article

Inhibition of Enveloped Virus Infection of Cultured Cells by Valproic AcidVAZQUEZ-CALVO, Angela; SAIZ, Juan-Carlos; SOBRINO, Francisco et al.Journal of virology. 2011, Vol 85, Num 3, pp 1267-1274, issn 0022-538X, 8 p.Article

CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acidSCOGGAN, Kylie A; FRIEDMAN, Joseph H; BULMAN, Dennis E et al.Canadian journal of neurological sciences. 2006, Vol 33, Num 1, pp 68-72, issn 0317-1671, 5 p.Article

Increased rate of major malformations in offspring exposed to valproate during pregnancyWYSZYNSKI, D. F; NAMBISAN, M; SURVE, T et al.Neurology. 2005, Vol 64, Num 6, pp 961-965, issn 0028-3878, 5 p.Article

Dose dependence of fetal malformations associated with valproateVAJDA, Frank J; O'BRIEN, Terence J; GRAHAM, Janet E et al.Neurology. 2013, Vol 81, Num 11, issn 0028-3878, 999-1003 [5 p.]Article

THE KYNURENINE PATHWAY: A MISSING PIECE IN THE PUZZLE OF VALPROATE ACTION?MACIEJAK, P; SZYNDLER, J; TURZYNSKA, D et al.Neuroscience. 2013, Vol 234, pp 135-145, issn 0306-4522, 11 p.Article

Syndrome d'hypersensibilité médicamenteuse à l'acide valproïque = Valproate-induced hypersensitivity syndromePICART, N; PERIOLE, B; MAZEREEUW, J et al.La Presse médicale (1983). 2000, Vol 29, Num 12, pp 648-650, issn 0755-4982Article

Mechanisms of action of valproate : a commentatoryJOHANNESSEN, C. U.Neurochemistry international. 2000, Vol 37, Num 2-3, pp 103-110, issn 0197-0186Conference Paper

Sodium valproate use is associated with reduced parietal lobe thickness and brain volumePARDOE, Heath R; BERG, Anne T; JACKSON, Graeme D et al.Neurology. 2013, Vol 80, Num 20, pp 1895-1900, issn 0028-3878, 6 p.Article

Child development following in utero exposure: Levetiracetam vs sodium valproateSHALLCROSS, R; BROMLEY, R. L; IRWIN, B et al.Neurology. 2011, Vol 76, Num 4, pp 383-389, issn 0028-3878, 7 p.Article

Augmentation of Polysialic Acid by Valproic Acid in Early Postnatal Mouse Hippocampus and Primary Cultured Hippocampal NeuronsNATORI, Takamitsu; KODAIRA, Fumiaki; HIRASAWA, Takae et al.Journal of bioscience and bioengineering. 2008, Vol 105, Num 2, pp 164-167, issn 1389-1723, 4 p.Article

Congenital Gingival Hyperplasia in a Neonate with Foetal Valproate SyndromeRODRIGUEZ-VKZQUEZ, M; CARRASCOSA-ROMERO, M. C; PARDAL-FERNANDEZ, J. J. M et al.Neuropediatrics. 2007, Vol 38, Num 5, pp 251-252, issn 0174-304X, 2 p.Article

Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutationGALIMBERTI, C. A; DIEGOLI, M; SARTORI, I et al.Neurology. 2006, Vol 67, Num 9, pp 1715-1717, issn 0028-3878, 3 p.Article

Valproate embryopathy: Clinical and cognitive profile in 5 siblingsSCHORRY, Elizabeth K; OPPENHEIMER, Sonya G; SAAL, Howard M et al.American journal of medical genetics. 2005, Vol 133A, Num 2, pp 202-206, issn 0148-7299, 5 p.Article

High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdoseKANE, Sandra L; CONSTANTINER, Mangel; STAUBUS, Alfred E et al.The Annals of pharmacotherapy. 2000, Vol 34, Num 10, pp 1146-1151, issn 1060-0280Article

Use of mood stabilizers by hospitalized geriatric patients with bipolar disorderSANDERSON, D. R.Psychiatric services (Washington, D.C.). 1998, Vol 49, Num 9, pp 1145-1147, issn 1075-2730Article

Comparative Efficacy and Safety of Intravenous Valproate and Phenytoin in ChildrenRAI, Anuradha; AGGARWAL, Anju; MITTAL, Hema et al.Pediatric neurology. 2011, Vol 45, Num 5, pp 300-304, issn 0887-8994, 5 p.Article

Relation entre les concentrations plasmatiques d'acide valproïque et la survenue d'une hépatotoxicité = Relationship between plasma concentrations of valproic acid and hepatotoxicity in patients receiving high dosesGHOZZI, H; HAKIM, A; SAHNOUN, Z et al.Revue neurologique (Paris). 2011, Vol 167, Num 8-9, pp 600-606, issn 0035-3787, 7 p.Article

Safety of rapid intravenous valproate infusion in pediatric patientsMORTON, Lawrence D; O'HARA, Kathryn A; COOTS, B. Patrick et al.Pediatric neurology. 2007, Vol 36, Num 2, pp 81-83, issn 0887-8994, 3 p.Article

Augmentation de la réplication in vitro de l'herpèsvirus humain 6 en présence de valproate de sodium = Enhancement of human herpesvirus 6 replication using sodium valproateMARDIVIRIN, L; LACROIX, A; DELEBASSEE, S et al.Virologie (Montrouge). 2007, Vol 11, Num 2, pp 151-153, issn 1267-8694, 3 p.Article

Les syndromes parkinsoniens médicamenteux = Drug-induced parkinsonimsNGUYEN, Nhan; PRADEL, Vincent; MICALLEF, Joëlle et al.Thérapie (Paris). 2004, Vol 59, Num 1, pp 105-112, issn 0040-5957, 8 p.Conference Paper